Related Experiment Video
Updated: Aug 25, 2025

3D Imaging of the Liver Extracellular Matrix in a Mouse Model of Non-Alcoholic Steatohepatitis
Published on: February 25, 2022
Molecular Advances in MAFLD-A Link between Sphingolipids and Extracellular Matrix in Development and Progression to
Adrian Kołakowski1, Sylwia Dziemitko1, Aleksandra Chmielecka1
1Department of Physiology, Medical University of Bialystok, 15-089 Bialystok, Poland.
Abstract:
Metabolic-Associated Fatty Liver Disease (MAFLD) is a major cause of liver diseases globally and its prevalence is expected to grow in the coming decades. The main cause of MAFLD development is changed in the composition of the extracellular matrix (ECM). Increased production of matrix molecules and inflammatory processes lead to progressive fibrosis, cirrhosis, and ultimately liver failure. In addition, increased accumulation of sphingolipids accompanied by increased expression of pro-inflammatory cytokines in the ECM is closely related to lipogenesis, MAFLD development, and its progression to fibrosis. In our work, we will summarize all information regarding the role of sphingolipids e.g., ceramide and S1P in MAFLD development. These sphingolipids seem to have the most significant effect on macrophages and, consequently, HSCs which trigger the entire cascade of overproduction matrix molecules, especially type I and III collagen, proteoglycans, elastin, and also tissue inhibitors of metalloproteinases, which as a result cause the development of liver fibrosis.
Insights
Sphingolipids like ceramide and S1P drive Metabolic-Associated Fatty Liver Disease (MAFLD) progression by altering the liver
Area of Science:
- Hepatology and Molecular Biology
- Extracellular Matrix Research
Background:
- Metabolic-Associated Fatty Liver Disease (MAFLD) is a growing global health concern.
- Dysregulation of the extracellular matrix (ECM) and inflammation are key drivers of MAFLD.
- Sphingolipid accumulation, particularly ceramides and S1P, is implicated in MAFLD pathogenesis.
Purpose of the Study:
- To review and summarize the role of sphingolipids in MAFLD development.
- To elucidate the mechanisms by which sphingolipids contribute to liver fibrosis.
Main Methods:
- Literature review and synthesis of existing research on sphingolipids and MAFLD.
- Analysis of the impact of sphingolipids on cellular components like macrophages and hepatic stellate cells (HSCs).
Main Results:
- Sphingolipids, including ceramide and S1P, significantly influence macrophage and HSC activity.
- This sphingolipid-mediated activation triggers excessive production of ECM components, notably collagen types I and III.
- Increased expression of tissue inhibitors of metalloproteinases also contributes to fibrosis development.
Conclusions:
- Sphingolipids are critical mediators in the development and progression of MAFLD towards fibrosis.
- Targeting sphingolipid metabolism may offer a therapeutic strategy for MAFLD and liver fibrosis.
Related Concept Videos
Intracellular Signaling Affects Focal Adhesions
Some...
Extracellular Matrix
The Extracellular Matrix
In order to maintain tissue organization, many animal cells are surrounded by structural molecules that make up the extracellular matrix (ECM). Together, the molecules in the ECM maintain the structural integrity of tissue as well as the remarkable specific properties of certain tissues.
Composition of the Extracellular Matrix
The extracellular matrix (ECM) is commonly composed of ground substance, a gel-like fluid, fibrous components, and many structurally and functionally diverse...
Cell-matrix's Response to Mechanical Forces
Anchoring junctions mechanically attach a cell to the...
Overview of Cell-Matrix Interactions
Role of Matrix Metalloproteases in Degradation of ECM

